PITUITARY ADENOMAS IN CHILDHOOD: DEVELOPMENT AND DIAGNOSIS

REFERENCES

• Gold FB. Epidemiology of pituitary adenomas. Epidemiol Rev 3:163–183, 1981.
   PubMed Web of Science ®Google Scholar
• Kane LA, Leinung MC, Scheithauer BW. , et al. Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab 79:1135–1140, 1994.
   PubMed Web of Science ®Google Scholar
• Pandey P, Ojha BK, Mahapatra AK. Pediatric pituitary adenoma: a series of 42 patients. J Clin Neuroscience 12:124–127, 2005.
   Google Scholar
• Partington MD, Davis DH, Laws ER, Jr; , et al. Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J Neurosurg 80:209–16, 1994.
   PubMed Web of Science ®Google Scholar
• Haddad SF, VanGilder JC, Menezes AH. Pediatric pituitary tumors. Neurosurgery 29:509–514, 1991.
   Google Scholar
• Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocrine Rev 19:798–827, 1998.
   PubMed Web of Science ®Google Scholar
• Sloop KW, Parker GI, Rhodes SJ. Transciptionalr regulation in mammalian pituitary development and disease. Curr Genomics 2:379–398, 2001.
   Google Scholar
• Tran PV, Savage JJ, Inhgraham HA, , et al. Molecular genetics of hypothalamic-pituiary axis development. In Pediatric Endocrinology, Mechanism, Manifestations and Management. Pescovitz OH and Eugster EA, eds. Philadelphia: Lippincott Williams and Williams, 64–79, 2004.
   Google Scholar
• Treier M, Gleiberman AS, O' Connell SM, , et al. Multi step signaling requirements of pituitary organogenesis in vivo. Geeses Dev 12:1691–1704, 1994.
   Google Scholar
• Treier M, O'Connell S, Gleiberman A, , et al. Hedgehog signaling is required for pituitary gland development. Development 128:377–386, 2001.
   PubMed Web of Science ®Google Scholar
• Sloop KW, Meier BC, Bridwell JL, , et al. Differential ativation of pituitary hormone genes by Lhx3 i.isoforms with distinct DNA binding properties. Mol Endocrinol 13:2212–2225, 1999.
   PubMedGoogle Scholar
• Netchine I, Sobrier ML, Krude H, , et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 25:182–186, 2000.
   PubMed Web of Science ®Google Scholar
• Sheng HZ, Moriyama K, Yaamashit T, , et al. Multistep control of pituitary organogenesis. Science 278:1809–1812, 1997.
   PubMed Web of Science ®Google Scholar
• Thomas PQ, Dattani MT, Brickman JM, , et al. Heterozygous HESXl mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 10:39–45, 2001.
   PubMed Web of Science ®Google Scholar
• Szeto DP, Ryan AK, O'Connell SM, , et al. P-OTX: a PIT-l interacting homeodomain factor expressed during anterior pituitary gland development. Proc Natl Acad Sci USA 93:7706–7710, 1996.
   PubMed Web of Science ®Google Scholar
• Ericson J, Norlin S, Jessell TM, , et al. Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 8:125:1005–1015, 1998.
   Google Scholar
• Parks JS, Tenore A, Bongiovanni AM, , et al. Familial hypopituitarism with large sella turcica. N Engl J Med 298:698–702, 1978.
   Google Scholar
• Pernasetti F, Toledo SP, Vasilyev VV, , et al. Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. J Clin Endocrinol Metab 85:390–397, 2000.
   PubMed Web of Science ®Google Scholar
• Rhodes SJ, DiMattia GE, Rosenfeld MAG. Transcriptional mechanisms in anterior pituitary cell differentiation. Cur Opin Genet Dev 4:709–717, 1994.
   PubMed Web of Science ®Google Scholar
• Shimon I, Melmed S. Genetic basis of endocrine disease. Pituitary tumor pathogenesis. J Clin Endocriol Metab 82(6):1675–1681, 1997.
   PubMed Web of Science ®Google Scholar
• Herman V, Fagin J, Gonsky R, , et al. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71:1427–1433, 1990.
   PubMed Web of Science ®Google Scholar
• Biller BMK, Alexander JM, Zervas NT, , et al. Clonal origins of adrenocorticotropin-secreting pituitary tissue in cushing's disease. J Clin Endocrinol Metab 75:1303–1309, 1992.
   Google Scholar
• Alexander JM, Biller BMK, Bikkal H, , et al. Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest 86:336–340, 1990.
   PubMed Web of Science ®Google Scholar
• Molitch M. Pathogenesis of pituitary tumors. Endocrinol Metab Clin 16:503–527, 1987.
   Google Scholar
• Ezzat S, Asa SL, Stefaneanu L, , et al. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone producing bronchial carcinoid. J Clin Endocrinol Metab 78:555–560, 1994.
   Google Scholar
• Gesundheit N, Petrick PA, Nissim M, , et al. Thyrotorpin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med 111:827–835, 1989.
   Google Scholar
• Bystrom C, Larrson C, Blomberg C, , et al. Localization of the MENl gene to a small region within chromosome llq13 by deltion mapping in tumors. Proc Natl Acad Sci USA 87:1968–1972, 1990.
   PubMed Web of Science ®Google Scholar
• Boggild MD, Jenkinson S, Pistorello M, , et al. Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab 778:387–392, 1994.
   Google Scholar
• Asa SL, Somers K, Ezzat S. The MEN-1 gene is rarely down-regulated in pituitary adenomas. J Clin Endocrinol Metab 83:3210–3212, 1998.
   PubMed Web of Science ®Google Scholar
• Imering MB, Brandi ML, deGrange DA, , et al. Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type l: relation to pituitary tumor. J Clin Endocrinol Metab 70:149–154, 1990.
   Google Scholar
• Nusinzon I, Horvath CM. Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation. Sci STKE, (296):re11, 2005.
   Google Scholar
• Jacks T, Fazeli A, Schmitt EM, , et al. Effects of an RB mutation in the mouse. Nature 359:295–300, 1992.
   PubMed Web of Science ®Google Scholar
• Pei L, Melmed S, Scheithauer B, , et al. Frequent loss of heterozygosity at the retinoblastoma gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55:1613–1616, 1995.
   PubMed Web of Science ®Google Scholar
• Woloschak M, Yu A, Xiao J, , et al. Frequent loss of the P16INK4 a gene product in human pituitary tumors. Cancer Res 56:2493–2496, 1996.
   PubMed Web of Science ®Google Scholar
• Levy A, Hall L, Yeundall WA, , et al. p53 Gene mutations in pituitary adenomas: rare events. Clin Endocrinol (Oxf) 41:809–814, 1994.
   PubMed Web of Science ®Google Scholar
• McAndrew J, Paterson AJ, Asa SL, , et al. Targeting of transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136:4479–4488, 1996.
   Google Scholar
• LeRiche V, Asa SL, Ezzat S. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumors aggressiveness. J Clin Endocrinol Metab 81:656–662, 1996.
   PubMed Web of Science ®Google Scholar
• Haddad G, Penabad JL, Bashey HM, , et al. Expression of activin/inhibin subunit messenger ribonucleic acids by gonadotroph adenomas. J Clin Endocrinol Metab 79:1399–1403, 1994.
   Google Scholar
• Abbass SA, Asa SL, Ezzat S. Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J Clin Endocrinol Metab 82:1160–1166, 1997.
   PubMed Web of Science ®Google Scholar
• Spada A, Vallar L, Gaflia G. G protein oncogenes in pituitary tumors. Trend Endocrinol Metab 3:355–360, 1992.
   Google Scholar
• Vallar L, Spada A, Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330:566–568, 1987.
   PubMed Web of Science ®Google Scholar
• Williamson EA, Ince PG, Harrison D, , et al. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest 25:128–131, 1995.
   PubMed Web of Science ®Google Scholar
• Pei L, Melmed S, Scheithauer B, , et al. H-ras mutations in human pituitary carcinoma metastasis. J Clin Endocrinol Metab 78:842–846, 1994.
   PubMed Web of Science ®Google Scholar
• Saeger W. Tumor-like lesions of the pituitary and sellar region. Endocrinologist 12:300–314, 2002.
   Google Scholar
• Root AW, Shulman DI. Clinical adrenal disorders. In Pediatric Endocrinology, Manifestations, Mechanisms and Management. Pescovitz OH and Eugster EA, eds. Philadelphia: Lippincott Williams and Wilkins, 568–600, 2004.
   Google Scholar
• Magiakou MA, Mastorakos G, Oldfield EH, , et al. Cushing's syndrome in children and adolescents. Presentation, diagnosis and therapy. N Engl J Med 331:629–636, 1994.
   PubMed Web of Science ®Google Scholar
• Lindholm, J, Juul S, Jorgensen JOL, , et al. Incidence and late prognosis of cushing's syndrome: A population-based study. J Clin Endocrinol Metab 86:117–123, 2001.
   PubMed Web of Science ®Google Scholar
• Margioris AN, Chrousos GP. Clinical presentation and diagnosis of Cushing's syndrome. In Adrenal Disorders. Margioris AN and Chrousos GP, eds. Totowa, NJ: Humana Press, 179–192, 2001.
   Google Scholar
• Bonat S, Stratakis CA. Cushing's syndrome in children. In Pediatric Endocrinology: A Practical Clinical Guide. Radovick S and MacGillivray M, eds. Totowa, NJ: Humana Press, 249–259, 2003.
   Google Scholar
• Devoe DJ, Miller WL, Conte FA, , et al. Long term outcome in children and adolescents after transphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 82:3196–3202, 1997.
   Google Scholar
• Stratakis CA, Mastorakos G, Mitsiades NS, , et al. Skin manifestations of Cushing's disease in children and adolescents before and after the resolution of hypercortisolemia. Pediatr Dermatol 15:253–258, 1998.
   Google Scholar
• Chiodini I, Carnevale V, Torlotano M, , et al. Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 83:1863–1867, 1998.
   PubMed Web of Science ®Google Scholar
• Stratakis CA. Early identification of Cushing syndrome. Pediatr Endocrinol 4:1–2, 2001.
   Google Scholar
• Papanicolaou DA, Yanovski JA, Cutler GB Jr, , et al. A Single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 83:1163–1167, 1998.
   Google Scholar
• Gafni RI, Papanicolaou DA, Nieman LK. Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents. J Pediatr 137:30–35, 2000.
   Google Scholar
• Raff H, Raff JL, Findling JW. Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 83:1163–1167, 1998.
   Google Scholar
• Streeten DHP, Faas FH, Elders MJ, , et al. Hypercortisolism in childhood: shortcomings of conventional diagnostic criteria. Pediatrics 56:797–803, 1975.
   Google Scholar
• Boscaro M, Barzon L, Fallo F, , et al. Cusning's syndrome. Lancet 357:783–791, 2001.
   PubMed Web of Science ®Google Scholar
• Batista D, Courkoutsakis NA, Oldfield EH, , et al. Detection of adenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with Cushing's disease. J Clin Endocrinol Metab 90:5134–5140, 2005.
   PubMed Web of Science ®Google Scholar
• Bonelli FS, Huston 3rd J, Carpenter PC, , et al. Adrenocorticotropic hormone-dependent Cushing's syndrome: sensitivity and specificity of inferior petrosal sinus sampling. Am J Neuroradiol 21:690–696, 2000.
   Google Scholar
• Hawass NE. Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients. Br J Radiol 70:360–366, 1997.
   PubMed Web of Science ®Google Scholar
• Peck WW, Dillon WP, Norman D, , et al. High resolution MR imaging of pituitary micoradenomas at 1.5 T: experience with Cushing disease. Am J Radiol 152:145–151, 1989.
   Google Scholar
• Kunwar S, Wilson CB. Pediatric pituitary adenomas. J Clin Endocrinol Metab 84:4385–4389, 1999.
   Google Scholar
• Fideleff HL, Boquete HR, Sequera A, , et al. Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches. J Pediatr Endocrinol Metab 13:261–267, 2000.
   Google Scholar
• Yazigi RA, Quiontero CH, Salameh WA. Prolactin disorders. Fertil Steril 67:215–225, 1997.
   PubMed Web of Science ®Google Scholar
• Colao A, Loche S, Cappa M, , et al. Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. J Clin Endocrinol Metab 183:2777–2780, 1998.
   Google Scholar
• Postel-Vinay M-C, Djiane J. Growth hormone and prolactin: biochemistry and physiology. In Pediatric Endocrinology, Physiology, Pathophysiology and Clinical Aspects, 2nd ed. Bertrand J, Rappaport R, and Sizonenko PC, eds. Baltimore: Willianms and Wilkins, 210–220, 1993.
   Google Scholar
• Thorner MO, Vance ML, Horvath D, , et al. The anterior pituitary. In Williams Textbook of Endocrinology, 8th ed. Wilson JD and Foster DW, eds. Philadelphia: WB Saunders, 221–310, 1992.
   Google Scholar
• Beck W, Wuttke W. Diurnal variations of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in boys and girls from birth to puberty. J Clin Endocrol Metab 50:635, 1980.
   PubMed Web of Science ®Google Scholar
• Shulman DI. Hyperprolactinemia in adolescents. Adolesc Pediatr Gynecol 8:213–215, 1995.
   Google Scholar
• Mindermann T, Chalrs B, Wilson MD. Pediatric pituitary adenomas. Neurosurgery 36:259–269, 1995.
   PubMed Web of Science ®Google Scholar
• Batrinos ML, Panitsa-Faflia C, Tsignaou E, , et al. Contribution to the problem of hyperprolactinemia: experience with 4,199 prolactin assays and 117 prolactinomas. Int J Fertile Menopaus Stud 39:120, 1994.
   PubMed Web of Science ®Google Scholar
• Oiwa A, Sakurai A, Sato Y. Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type l. Endocrine J 49:635–640, 2002.
   Google Scholar
• Guru SC, Manickam P, Crabtree JS, , et al. Identification and characterization of the multiple endocrine neoplasia type l (MEN1) gene. J Intern Med 243:433, 1998.
   Google Scholar
• Verges B, Boureille F, Goudet P, , et al. Pituitary disease in MEN type l (MENl): data from the France-Belgium MENl muticenter study. J Clin Endocrinol Metab 87:457–465, 2002.
   PubMed Web of Science ®Google Scholar
• Evans WS, Thorner MO. Mechanism for hypogonadism in hyperprolactinemia. Semin Reprod Endocrinol 2:9–15, 1981.
   Google Scholar
• Duntas LH. Prolactinomas in children and adolescents-consequences in adult life. J Pediatr Endocrinol Metab 14:1227–1232, 2001.
   Google Scholar
• Glickman SP, Rosenfeld RL, Bergenstal RM, , et al. Multiple androgenic abnormalities including elevated free testosterone in hyperprolactinemic women. J Clin Endocrinol Metab 55:251, 1982.
   PubMed Web of Science ®Google Scholar
• Frantz AG, Wilson JD. Endocrine disorders of the breast. In Williams Textbook of Endocrinology, 8th ed. Wilson JD and Foster DW, eds. Philadelphia: WB Saunders, 962–968, 1992.
   Google Scholar
• Gelber SJ, Heffez DS, Donohoue PA. Pitutiary gigantism caused by growth hormone excess from infancy. J Pediatr 120:931–934, 1992.
   Google Scholar
• Extabe J, Gastambide S, Latorre P, , et al. Acromegaly: an epidemiological study. J Endocrinol Invest 16:181–187, 1993.
   PubMedGoogle Scholar
• Dubuis JM, Deal CL, Drews RT, , et al. Mammosomatotroph adenoma causing gigantism in an 8-year-old boy. A possible pathogenetic mechanism. Clin Endocrinol (Oxf) 42:539–549, 1995.
   Google Scholar
• Feliz IA, Horvath E, Kovacs K, , et al. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy. Acta Neuropathol 71:76–82, 1986.
   Google Scholar
• Eugster EA, Pescovitz OH. Gigantism. J Clin Endocrinol Metab 84:4379–4384, 1999.
   Google Scholar
• Shimon I, Melmed S. Genetic basis of endocrine disease. Pituitary tumor pathogenesis. J Clin Endocrinol Metab 82:1675–1681, 1997.
   PubMed Web of Science ®Google Scholar
• Dotsch J, Kiess W, Hanze J, , et al. Gs alpha mutation at codon 201 in pituitary adenoma causing gigantism in a 6 year old boy with McCune-Albright syndrome. J Clin Endocrinol Metab 81:3839–3842, 1996.
   PubMed Web of Science ®Google Scholar
• Root AW, Diamond FB, Jr. Overgrowth syndromes: evaluation and management of the child with excessive linear growth. In Pediatric Endocrinology, 5th ed. Lifschitz F, ed., 2:163–194.
   Google Scholar
• Allen DB, Geffner ME, eds. Principles and Practice of Pediatric Endocrinology. Springfield, IL: Charles C. Tomas, 77–216, 2005.
   Google Scholar
• Alikasifoglu A, Kandemir N, Akalan N, , et al. Pituitary adenoma associated with gigantism and hyperprolactinemia. Pediatr Neurosurg 35:325–328, 2001.
   Google Scholar
• Thapar K, Kovacs, K, Scheithauer BW, , et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99–107, 1996.
   PubMed Web of Science ®Google Scholar
• Beck-Peccoz P, Brucker-Davis F, Persani L, , et al. Thyrotropin-secreting pituitary tumors. Endocrine Rev 17:610–638, 1996.
   PubMed Web of Science ®Google Scholar
• Weintraub BD, Petrick PA, Gesundheit N, , et al. TSH-secreting pituitary tumors. In Frontiers in Thyroidology. Mederiros-Neto G and Gaitan S, eds. New York: Plenum Publishing, 71–77, 1986.
   Google Scholar
• Gesundheit N, Petrick P, Nissim M, , et al. Thyrotorpin-secreting pituitary adenomas: clinical and biochemical heterogeneity, Ann Intern Med 111:827–835, 1989.
   Google Scholar
• Sanno N, Teramoto A, Osamura RY. thyrotropin-secreting pituitary adenomas. Clinical, and biological heterogeneity and current treatment. J Neuro-Oncol 54:179–186, 2001.
   PubMed Web of Science ®Google Scholar
• Nabarro JDN. Acromegaly. Clin Endocrinol (Oxf) 26:481–512, 1987.
   PubMed Web of Science ®Google Scholar
• Sergi I, Medr G, Papandreou MJ, , et al. Polymorphism of thyrotropin and α-subunit in human pituitary adenomas. J Endocrinol Invest 46:45–55, 1993.
   Google Scholar
• Sanno N, Teramoto A, Matsun A, , et al. Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1. Mod Pathol 7:893–899, 1994.
   Google Scholar
• Ridgway EC. Glycoprotein hormone production by pituitary tumors. In Secretory Tumors of the Pituitary Gland. Progress in Endocrine Research and Therapy l. Black PM, ed. New York: Raven Press, 343–350, 1984.
   Google Scholar
• Kourdies IA, Ridgeway EC, Weintraub BD, , et al. Thyrotropin-induced hyperthyroidism: use of α and β subunit levels to identify patients with primary pituitary tumors. J Clin Endocrinol Metab 45:534–543, 1977.
   Google Scholar
• Beck-Peccoz P, Persani L, Faglia G. Glycoprotein hormone α-subunit in pituitary adenomas. Trends Endocrinol Metab 3:41–45, 1992.
   Google Scholar
• Terzolo M, Orlandi F, Bassetti M, , et al. Hyperthyroidism due to pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another co-secreting alpha-subunit and thyrotropin. J Clin Endocrinol Metab 72:415–421, 1991.
   Google Scholar
• Brucker-Davis F, Oldfield EH, Skarulis MC, , et al. Thyrotropin-secreting pituitary tumors diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476–486, 1999.
   PubMedGoogle Scholar
• Beckers A, Abs R, Mahler C, , et al. Thryotropin-secreting pituitary adenomas: report of seven cases. J Clin Endocrinol Metab 732:477–483, 1991.
   Google Scholar
• Bertherot J, Brue T, Enjalbert A, , et al. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretion. J Clin Endocrinol Metab 75:540–546, 1992.
   Google Scholar
• Di Rocco C, Maira G, Borrelli P. Pituitary microadenomas in children. Child's Brain 9:165–178, 1982.
   Google Scholar
• Tashiro H, Katabuchi H, Ohtake H, , et al. An immunohistochemical and ultrastructural study of a follicle-stimulating hormone-secreting gonadotroph adenoma occurring in a 10-year-old girl. Med Electron Microsc 33:25–31, 2000.
   Google Scholar
• Chanson P, Young J. Pituitary incidentalomas. Endocrinologist 13:124–135, 2003.
   Google Scholar
• Bhansali A, Velayutham P, Radotra BD, , et al. Idiopathic granulomatous hypophysitis presenting as non-functioning pituitary adenoma: description of six cases and review of the literature. Br J Neurosurg 18:489–494, 2004.
   PubMed Web of Science ®Google Scholar
• Argyropoulou M, Perignon F, Brauner R, , et al. Magnetic resonance imaging in the diagnosis of growth hormone deficiency. J Pediatr 120:886–891, 1992.
   PubMed Web of Science ®Google Scholar
• Root AW, Martinez CR. Magnetic resonance imaging in patients with hypopituitarism. Trends Endocrinol Metab 3:283–287, 1992.
   Google Scholar
• Martinez CR. MRI precisely delineates pituitary gland (athology). Diag Imaging 104–109, 1991.
   Google Scholar